DNA methylation of ANKK1 and response to aripiprazole in patients with acute schizophrenia: A preliminary study.

[1]  H. Yabe,et al.  Associations between five-factor model of the Positive and Negative Syndrome Scale and plasma levels of monoamine metabolite in patients with schizophrenia , 2015, Psychiatry Research.

[2]  H. Yabe,et al.  Influence of −141C Ins/Del Polymorphism in DRD2 Gene on Clinical Symptoms and Plasma Homovanillic Acid Levels in the Treatment of Schizophrenia With Aripiprazole , 2015, Journal of clinical psychopharmacology.

[3]  A. Kakita,et al.  Elevated postmortem striatal t-DARPP expression in schizophrenia and associations with DRD2/ANKK1 polymorphism , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[4]  G. Reynolds,et al.  Methylation at a transcription factor-binding site on the 5-HT1A receptor gene correlates with negative symptom treatment response in first episode schizophrenia. , 2014, The international journal of neuropsychopharmacology.

[5]  G. Reynolds,et al.  Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms. , 2014, British journal of clinical pharmacology.

[6]  K. Kasai,et al.  Comprehensive DNA methylation analysis of human neuroblastoma cells treated with blonanserin , 2014, Neuroscience Letters.

[7]  V. Corces,et al.  CTCF: an architectural protein bridging genome topology and function , 2014, Nature Reviews Genetics.

[8]  K. Kasai,et al.  DNA methylation in schizophrenia: progress and challenges of epigenetic studies , 2012, Genome Medicine.

[9]  T. Lencz,et al.  Pharmacogenetics in psychiatry: translating research into clinical practice , 2012, Molecular Psychiatry.

[10]  S. Niwa,et al.  Effects of Aripiprazole and the Taq1A Polymorphism in the Dopamine D2 Receptor Gene on the Clinical Response and Plasma Monoamine Metabolites Level During the Acute Phase of Schizophrenia , 2012, Journal of clinical psychopharmacology.

[11]  Norio Sugawara,et al.  Comparing the Influence of Dopamine D2 Polymorphisms and Plasma Drug Concentrations on the Clinical Response to Risperidone , 2011, Journal of clinical psychopharmacology.

[12]  Felix Krueger,et al.  Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications , 2011, Bioinform..

[13]  A. Malhotra,et al.  D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis. , 2010, The American journal of psychiatry.

[14]  R. Yoshimura,et al.  Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[15]  Yu-jung Chen,et al.  Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients. , 2009, Journal of psychiatric research.

[16]  J. Kwon,et al.  Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole , 2008, European Neuropsychopharmacology.

[17]  Adrian Bird,et al.  Perceptions of epigenetics , 2007, Nature.

[18]  A. Malhotra,et al.  DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients. , 2006, The American journal of psychiatry.

[19]  M. Neville,et al.  Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1 , 2004, Human mutation.

[20]  M. Nöthen,et al.  Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers , 1999, Molecular Psychiatry.

[21]  H. Arai,et al.  First-episode neuroleptic-free schizophrenics: Concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment , 1997, Biological Psychiatry.

[22]  J. Mill,et al.  Epigenetic studies of schizophrenia: progress, predicaments, and promises for the future. , 2013, Schizophrenia bulletin.